Introduction {#s1}
============

The genetic risk for obesity has been linked to more than 300 single nucleotide polymorphisms (SNP; Goodarzi, [@B17]). The fat mass and obesity associated (*FTO*) gene (Yang et al., [@B59]; Loos and Yeo, [@B29]), one of the first obesity-genes ever identified, remains nonetheless one of the most strongly associated with obesity (Goodarzi, [@B17]). The association between risk-variants of the *FTO* gene and obesity seems not to be mediated by peripheral factors such as a dysfunctional metabolism (Cecil et al., [@B6]; Speakman et al., [@B50]), but rather by increased dietary intake and unhealthy eating behaviors (Brunkwall et al., [@B3]), probably linked to an aberrant functioning of the reward network (Hess et al., [@B20]; Sevgi et al., [@B44]). The reward network encompasses several brain regions in the cortico-basal ganglia-thalamo-cortical loop (Yager et al., [@B58]), in which the nucleus accumbens (Camara et al., [@B4]) and thalamus (Yager et al., [@B58]) play a key role. It can be divided into different specialized sub-networks (Camara et al., [@B4]), and exerts several complex functions in human behavior, including reinforcement learning, novelty processing, decision making, incentive motivation, and addiction (Camara et al., [@B4]). Given its complexity, its activity is closely associated to that of other main networks, such as the salience network, the emotional arousal network and the executive network (Gupta et al., [@B18]). Brain structural and functional connectivity changes in the reward system, closely resembling those observed in addiction (Michaud et al., [@B67]), have also been reported in obesity (Marqués-Iturria et al., [@B30]; Blechert et al., [@B65]; Carnell et al., [@B66]; Papageorgiou et al., [@B36]; Verdejo-Román et al., [@B68]), affecting several tracts (e.g., the anterior thalamic radiation, accumbofrontal fasciculus, forceps minor (FMi), cingulum, superior longitudinal fasciculus, inferior fronto-occipital fasciculus (Cho et al., [@B8]; Marqués-Iturria et al., [@B30]; Kullmann et al., [@B26]; Nangunoori et al., [@B34]; Papageorgiou et al., [@B36])) of the reward pathway (Sesack and Grace, [@B43]; Xu et al., [@B57]; Bracht et al., [@B2]; Yang et al., [@B60]). Only few studies, however, have investigated whether structural connectivity might be disrupted in people with genetic risk for obesity (Dennis et al., [@B12]; Spieker et al., [@B51]), reporting somewhat conflicting results.

The *FTO* gene modulates the activity of the midbrain reward circuitry by regulating the activity of the receptors D2 and D3 (Hess et al., [@B20]; Sevgi et al., [@B44]; Heni et al., [@B19]), providing a potential mechanism for the increased risk for obesity associated to the *FTO* risk-variants. In fact, an aberrant dopaminergic signaling in reward-related regions has been often reported in obesity (Frank, [@B15]), particularly through the hyposensitivity of receptors D2 and D3 (Frank, [@B15]). Moreover, dopaminergic receptors are involved in neurovascular coupling and pressure regulation (Perles-Barbacaru et al., [@B38]), which is associated with white matter (WM) structural integrity (Sorond et al., [@B48]; Chapman et al., [@B7]), and exerts an important role in neuroinflammatory processes (Soto et al., [@B49]; Wilhelm et al., [@B56]). The thalamus and the nucleus accumbens seem to be particularly vulnerable to blood pressure dysregulation, due their peculiar anatomo-vascular characteristics (Moody et al., [@B32]; Perles-Barbacaru et al., [@B38]; Iozzo, [@B22]). Accordingly, the gray matter (GM) volume of the nucleus accumbens has been reported to be lower in the at-risk AA carriers of the *FTO* SNP rs9939609 (de Groot et al., [@B10]).

We suggest that the *FTO* risk-allele might be associated with WM microstructural damage in specific reward-related regions, namely the thalamus and nucleus accumbens, particularly vulnerable to blood pressure dysregulation (Moody et al., [@B32]; Perles-Barbacaru et al., [@B38]; Iozzo, [@B22]). The subsequent WM disruption in regional connectivity might be a predisposing factor for the development of obesity. The disruption of other reward system tracts would then follow, depending on whether clinical obesity is developed.

To test our hypothesis, we have focused on 21 male participants genotyped for *FTO* SNP rs9939609. Variants of the SNP rs9939609 of the *FTO* gene are linked to an increased risk for obesity (Yang et al., [@B59]; Loos and Yeo, [@B29]), with the AA genotypes considered at-risk compared to the TT genotype (Frayling et al., [@B16]; Jacobsson et al., [@B23]; Sällman Almén et al., [@B42]). We have investigated whether an association existed between genotype, body mass index (BMI) and diffusivity parameters of WM, reflective of WM microstructural integrity, in the "risk tracts" (anterior thalamic radiation and accumbofrontal fasciculi) and the "obesity-associated tracts" (FMi, cingulum, superior longitudinal fasciculus, inferior fronto-occipital fasciculus). These tracts were selected for their role in reward and punishment sensitivity (Sesack and Grace, [@B43]; Xu et al., [@B57]; Bracht et al., [@B2]; Yang et al., [@B60]), and for their involvement in obesity (Cho et al., [@B8]; Marqués-Iturria et al., [@B30]; Kullmann et al., [@B26]; Nangunoori et al., [@B34]; Papageorgiou et al., [@B36]). Moreover, we explored whether WM diffusivity could be related to specific personality traits in terms of punishment and reward sensitivity, as measured by the BIS/BAS (Carver and White, [@B5]) questionnaire.

Materials and Methods {#s2}
=====================

Participants {#s2-1}
------------

Prior to any experimental procedures, all participants gave written informed consent to the study which conformed to the Declaration of Helsinki and was approved by the Ethical Review Board of Uppsala, Sweden. Participants were 21 right-handed, northern-European males, with a mean age of 25 years (±2.0 years; range 20--28 years), recruited locally in Uppsala, Sweden by advertisement. Genotyping of the *FTO* single nucleotide polymorphism (SNP) rs9939609 was performed with a pre-designed Taqman single-nucleotide polymorphism genotyping assay (Applied Biosystems, Foster City, CA, USA) and an ABI7900 genetic analyzer with SDS 2.2 software at the Uppsala Genome Center[^1^](#fn0001){ref-type="fn"}. The genotype call rate was 97.8%. Only homozygous participants were included in the study. Nine participants were homozygous for the risk A allele, 12 participants were homozygous for the non-risk T allele. The mean BMI of the sample was 25.2 Kg/m^2^ (±3.4 Kg/m^2^; range 20.4--32.9 Kg/m^2^). The demographic data of the participants are reported in Table [1](#T1){ref-type="table"}.

###### 

Demographics and neuropsychological scores of the participants.

                                AA genotype (mean; SD)   TT genotype (mean; SD)
  ----------------------------- ------------------------ ------------------------
  *Age (years)*                 25 (± 2.6)               25 (± 1.6)
  *BMI (Kg/m^2^)*               26.4 (± 3.7)             24.3 (± 3.0)
  *BMI \> 30 Kg/m^2^*           *N* = 2                  *N* = 1
  *BIS/BAS ratio*               2.1 (± 0.6)              2.1 (± 0.5)
  *BAS Drive*                   8.9 (± 1.8)              7.7 (± 2.4)
  *BAS Fun Seeking*             13.1 (± 1.9)             11.3 (± 2.8)
  *BAS Reward Responsiveness*   15.4 (± 2.3)             16.4 (± 1.8)
  *BIS*                         18.2 (± 3.0)             17.7 (± 4.1)

Neuropsychological Testing {#s2-2}
--------------------------

Clinical measures for punishment sensitivity and reward-seeking behavior were acquired through the Behavioral Inhibition and Activation Systems (BIS and BAS, respectively) questionnaires (Carver and White, [@B5]). The BIS is associated with behavioral withdrawal, punishment and unhealthy behavior (Carver and White, [@B5]; Voigt et al., [@B53]), while the BAS reflects impulsivity, approach behaviors and reward sensitivity (Carver and White, [@B5]). The questionnaire is composed of 24 items. Each item is represented by a statement, which the participants indicates how much he agrees or disagrees with on a four-point scale. The BIS includes only one scale, evaluating the reactions to the anticipation of punishment and anxiety. The BAS comprises three subscales: (1) the Drive scale is pertinent to the pursuit of desired goals; (2) the Fun Seeking scale evaluates the desire for new rewards and impulsivity; and (3) the Reward Responsiveness scale focuses on the positive reactions anticipating the rewards. The BIS/BAS ratio (BBr) was also calculated, which reflects the imbalance between the Activation and Inhibition system.

DTI Acquisition {#s2-3}
---------------

MRI scanning was performed with a Philips 3-Tesla (Achieva, Philips Healthcare, Best, Netherlands) using a 32-channel head coil. Diffusion tensor imaging (DTI) data were acquired using an echoplanar imaging sequence (TR: 6700 ms, TE: 77 ms, voxel size: 1.75 × 1.75 × 1.75 mm^3^, 1 b0, b value = 1000, 48 directions, 60 axial slices covering the whole brain). During the MRI study, the participants lay supine with the head fixed by straps and foam pads to minimize head movement.

DTI Pre-processing {#s2-4}
------------------

All pre-processing steps were carried out in FMRIB Software Library (FSL, provided in the public domain by the Oxford Centre for Functional Magnetic Resonance Imaging of the Brain; Jenkinson et al., [@B24]). DTI images were first corrected for eddy currents and head motion using the FMRIB's Diffusion Toolbox (FDT) implemented in FSL, then brain images were extracted using the brain extraction tool (BET; Smith, [@B46]). All scans were visually inspected to check for artifacts and ensure good quality of the acquisition. The diffusion tensor model was then fitted at each voxel using Diffusion Toolkit[^2^](#fn0002){ref-type="fn"}, obtaining fractional anisotropy (FA) and apparent diffusion coefficient (ADC) maps. FA measures the fraction of water molecules preferentially moving along the major axis of the axons, and reflects the overall integrity of the fiber (Alexander et al., [@B1]). ADC reflects the impedance of water molecules, with higher ADC values associated to higher space between myelin sheets layers (Alexander et al., [@B1]). The maximum turning angle was set at 35° (Diffusion Toolkit default) and minimum FA was set at 0.1 (Soares et al., [@B47]) for DTI reconstruction.

Tractography {#s2-5}
------------

The tractography analysis was performed with Trackvis[^3^](#fn0003){ref-type="fn"}. Eleven WM tracts were selected *a priori* for tractography based on previous literature and manually identified: FMi (Papageorgiou et al., [@B36]), right and left anterior thalamic radiations (ATR; Kullmann et al., [@B26]; Papageorgiou et al., [@B36]), right and left cingulum (Papageorgiou et al., [@B36]), right and left accumbofrontal fasciculi (Cho et al., [@B8]; Marqués-Iturria et al., [@B30]; Nangunoori et al., [@B34]), right and left inferior longitudinal fascicule (IFOF; Papageorgiou et al., [@B36]), right and left superior longitudinal fasciculi (SLF; Kullmann et al., [@B26]; Papageorgiou et al., [@B36]). The ROIs were drawn according to Wakana et al. ([@B55]), except for the accumbofrontal fasciculus, which was drawn based on Rigoard et al. ([@B40]) and Vergani et al. ([@B52]) studies. According to Wakana et al. ([@B55]), the cingulum was split into a cingulate gyrus part, and a hippocampal part (CGH); the SLF was also divided in SLF, and temporal part of the SLF. In addition, the forceps major, which is not directly involved in reward, was selected as control tract, for a total of 16 selected tracts/subdivisions. FSL was used to extract the FA, ADC and volume of each tract.

Networks Selection {#s2-6}
------------------

According to our hypothesis, the tracts were divided into "risk tracts", comprising the accumbofrontalfasciculi and ATR (Figure [1](#F1){ref-type="fig"}), and "obesity-associated tracts", comprising the cingulum (Ci) subdivisions, the SLF subdivisions, the IFOF and the FMi (Figure [2](#F2){ref-type="fig"}). This approach was chosen according to differences in vulnerability to pressure dysregulation based on different patterns of vascular architecture. Basal ganglia nuclei have been reported to be particularly vulnerable to pressure dysregulation compared to the other regions (Moody et al., [@B32]; Perles-Barbacaru et al., [@B38]; Iozzo, [@B22]) and therefore included into the suspected "risk stage" of WM damage. Because of differences in collateral blood supply and anastomotic compensation of peripheral cortico-sub-cortical regions Ci, SLF, IFOF and FMi were considered as "obesity-associated tracts" (Moody et al., [@B32]; Perles-Barbacaru et al., [@B38]; Iozzo, [@B22]). Mean FA and ADC of all tracts are reported in Table [2](#T2){ref-type="table"}.

![Tractographic reconstruction of "risk tracts" overlaid on a representative high resolution T1-weighted sequence slices from the Montreal Neurological Institute space. The previously acquired tracks (from Trackvis) and the MRI sequence were merged within the MNI space using DSI software (DSI Studio; freely downloadable at <http://dsi-studio.labsolver.org/download-images>) utilized for illustrative purpose only. The anatomical relationship of the two "risk tracts" bundles (Accumbens-Frontal, blue and Anterior Thalamic Radiation (green) with nucleus Accumbens (red) and thalamus (yellow) bilaterally, are displayed in axial (superior view), coronal (anterior view) and sagittal) lateral left). The nucleus accumbens and the thalamus were reconstructed within the MNI Space using Freesurfer atlas included in the DSI studio software.](fnhum-12-00075-g0001){#F1}

![Tractographic reconstruction of "obesity-associated tracts" overlaid on a representative high resolution T1-weighted sequence slices from the Montreal Neurological Institute space. The previously acquired tracks (from Trackvis) and the MRI sequence were merged within the MNI space using DSI software (DSI Studio; freely downloadable at <http://dsi-studio.labsolver.org/download-images>) utilized for illustrative purpose only. The anatomical relationship of the bilateral "obesity-associated tracts" bundles (Arcuate fasciculus, pink; horizontal component of Superior longitudinal fasciculus, yellow; Inferior-fronto-occipital fasciculus, red; Cingulum, dark red and Forceps minor (FMi), blue) are displayed in axial (superior view), coronal (anterior view) and sagittal (lateral left view).](fnhum-12-00075-g0002){#F2}

###### 

Tracts characteristics.

                                                        Fractional anisotropy (mean; SD)   Apparent diffusion coefficient (mean; SD) (×10^−3^ mm^2^/s)   Volume (mean; SD) (number of tracts)
  ----------------------------------------------------- ---------------------------------- ------------------------------------------------------------- --------------------------------------
  Accumbofrontal Fasciculus, R                          0.34; 0.03                         0.80; 0.04                                                    956; 191
  Accumbofrontal Fasciculus, L                          0.34; 0.03                         0.82; 0.04                                                    1062; 254
  Anterior Thalamic Radiation, R                        0.37; 0.02                         0.80; 0.04                                                    860; 398
  Anterior Thalamic Radiation, L                        0.37; 0.02                         0.80; 0.04                                                    849; 363
  Cingulum, R (hippocampal part)                        0.32; 0.03                         0.85; 0.04                                                    408; 152
  Cingulum, L (hippocampal part)                        0.32; 0.04                         0.87; 0.04                                                    472; 169
  Cingulum, R (cingulate gyrus)                         0.42; 0.04                         0.74; 0.03                                                    351; 183
  Cingulum, L (cingulate gyrus)                         0.42; 0.06                         0.76; 0.04                                                    457; 154
  Forceps Major                                         0.48; 0.04                         0.89; 0.09                                                    1781; 495
  Forceps Minor                                         0.45; 0.04                         0.81; 0.04                                                    2216; 754
  Inferior Fronto-occipital Fasciculus, R               0.44; 0.02                         0.80; 0.02                                                    1479; 424
  Inferior Fronto-occipital Fasciculus, L               0.45; 0.02                         0.79; 0.02                                                    1361; 562
  Superior Longitudinal Fasciculus, R                   0.39; 0.02                         0.75; 0.02                                                    1242; 497
  Superior Longitudinal Fasciculus, L                   0.40; 0.02                         0.75; 0.02                                                    1073; 470
  Superior Longitudinal Fasciculus, R (temporal part)   0.43; 0.03                         0.73; 0.03                                                    442; 363
  Superior Longitudinal Fasciculus, L (temporal part)   0.42; 0.03                         0.75; 0.02                                                    902; 365

Statistical Analysis {#s2-7}
--------------------

All statistical analyses were performed with Statistical Package for Social Science (SPSS) v.24[^4^](#fn0004){ref-type="fn"}. Prior to all analyses, the FA and ADC values of each tract were corrected for the volume of the tract through a linear regression analysis. The standardized residuals were then used for subsequent analyses. Multiple separate analyses of variance (ANOVA) analyses were first carried out to test for an effect of genotype and/or an effect of the interaction between genotype and BMI, in FA and ADC values of each tract separately. An interaction exists when the effect of one explanatory variable (i.e., genotype) on an outcome variable (i.e., FA or ADC) depends on the level or value of another explanatory variable (i.e., BMI). The threshold for significance was set at *p* \< 0.003, to correct for multiple testing according to Bonferroni (0.05/16 tracts). Age was entered as nuisance covariate in the analysis.

To test our hypothesis, we then performed a multivariate analysis of variance (MANOVA) separately for the tracts included in the "risk" and "obesity-associated" network respectively. The FA and ADC values of the WM tracts were entered as dependent variables in different multivariate models respectively, and genotype and BMI were tested for main effects and interaction effect on the diffusivity parameters. Age was entered as nuisance covariate in all models. The model was also tested against the FA and ADC of the control tract (forceps major). The threshold for significance was set at *p* \< 0.05.

The FA and ADC of the tracts included in each network were also tested for correlation with the psychological scores, through a series of univariate analyses of variance models. For the BIS/BAS questionnaire, the four subscales and the BBr were tested in five different models. The threshold for significance was set at *p* \< 0.01, to allow for multiple testing correction according to Bonferroni's approach (0.05/5). Age was again entered as nuisance covariate. In each model, the WM tracts comprising the network of interest were entered as independent variables.

Results {#s3}
=======

Difference in Diffusivity Parameters between Groups {#s3-1}
---------------------------------------------------

No effect of genotype or interaction between genotype and BMI was found on the tracts FA when tested separately with the ANOVA analyses. An effect of the genotype and of the interaction between genotype and BMI was found on the ADC of the right accumbofrontal fasciculus (*p* \< 0.022 and *p* \< 0.016, respectively), not surviving the correction for multiple testing. An effect of the genotype and of the genotype\*BMI interaction was also detected on the ADC of the right temporal part of the SLF (*p* \< 0.028 and *p* \< 0.026, respectively), not surviving the correction for multiple testing.

Association between Genotype, BMI and Diffusivity Parameters of the "Risk Tracts" {#s3-2}
---------------------------------------------------------------------------------

At the MANOVA analyses, the FA values of the "risk tracts" were found to be significantly associated to genotype (*F* = 4.45, df = 13, *p* \< 0.017) and to the interaction between genotype and BMI (*F* = 4.6, df = 13, *p* \< 0.015), though not to BMI *per se*. In particular, the FA (i.e., standardized residuals after correction for tracts volume) of the left ATR and of the right accumbofrontal fasciculus was lower, while the FA of the right ATR and left accumbofrontal fasciculus was higher, in the risk-allele carriers. The "obesity-associated tracts" did not correlate either with genotype, BMI nor their interaction, supporting our hypothesis. No association was found between genotype, BMI and the FA of the forceps major (Table [3](#T3){ref-type="table"}).

###### 

Main effects and interaction between genotype, BMI and diffusivity parameters.

  a\. risk-network                    Parameter       *F*     *η*^2‡^       Sig.
  ----------------------------------- --------------- ------- ------------- ----------
  *Genotype*                          FA              4.451   0.578         0.017\*
  *BMI*                               FA              1.035   0.242         0.426
  *Genotype\*BMI*                     FA              4.618   0.587         0.015\*
  *Genotype*                          ADC             2.072   0.389         0.143
  *BMI*                               ADC             2.450   0.430         0.098
  *Genotype\*BMI*                     ADC             2.266   0.411         0.118
  **b. obesity-associated network**   **Parameter**   *F*     ***η*^2‡^**   **Sig**.
  *Genotype*                          FA              0.854   0.610         0.612
  *BMI*                               FA              0.970   0.640         0.545
  *Genotype\*BMI*                     FA              0.990   0.645         0.534
  *Genotype*                          ADC             0.653   0.545         0.745
  *BMI*                               ADC             1.573   0.742         0.300
  *Genotype\*BMI*                     ADC             0.666   0.550         0.736

*η^2^ = partial eta squared. ^‡^Small effect size: 0.10 ≤ η^2^ \< 0.3; medium effect size: 0.3 ≤ η^*2*^ \< 0.5; large effect size: η^2^ ≥ 0.5. \*Significant with p \< 0.05*.

Genotype, BMI and their interaction between them had no effect on the ADC of the "risk" or "obesity-associated" WM tracts. No effect on the ADC of the forceps major was found either (Table [3](#T3){ref-type="table"}).

Association between the Neuropsychological Scores and "Risk Tracts" Diffusivity {#s3-3}
-------------------------------------------------------------------------------

When the BIS/BAS questionnaire scores were tested against "risk-tracts" and genotype, the FA of the right ATR significantly predicted the BBr (*p* \< 0.002) and BIS (*p* \< 0.000) scores (Table [4](#T4){ref-type="table"}, Figure [3](#F3){ref-type="fig"}). The FA of the right accumbofrontal fasciculus predicted the BIS (*p* \< 0.009). The Drive subscale of the BAS was found to be significantly associated with the ADC of the left ATR (*p* \< 0.01; Table [4](#T4){ref-type="table"}, Figure [3](#F3){ref-type="fig"}). The association between the ADC in the right ATR and the BIS subscale approached significance (*p* \< 0.05, uncorrected).

###### 

Significant correlations between the neuropsychological scores, genotype and the "risk-network" WM tracts.

  Score                              WM tract                 *F*    *η*^2‡^   Sig.
  ---------------------------------- ------------------------ ------ --------- ----------------
  *FRACTIONAL ANISOTROPY*                                                      
  BIS/BAS ratio                      Right ATR                15.0   0.518     0.002\*\*
  BIS                                Right ATR                35.3   0.716     4 × 10^−5^\*\*
                                     Right Fronto-Accumbens   9.2    0.396     0.009\*\*
  *APPARENT DIFFUSION COEFFICIENT*                                             
  BAS DRIVE                          Left ATR                 17.1   0.386     0.010\*\*
  BIS                                Right ATR                5.0    0.280     0.035

*η^2^ = partial eta squared. ^‡^Small effect size: 0.10 ≤ η^2^ \< 0.3; medium effect size: 0.3 ≤ η^2^ \< 0.5; large effect size: η^2^ ≥ 0.5. \*\*Significant after correction for multiple comparisons*.

![The psychological scores were tested for associations with genotype and the fractional anisotropy (FA) and apparent diffusion coefficient (ADC) of the tracts included in each network through a series of univariate analyses of variance models. For the BIS/BAS questionnaire, the four subscales and the BIS/BAS ratio (BBr) were tested in five different models. The threshold for significance was set at *p* \< 0.01, to allow for multiple testing correction according to Bonferroni's approach. Age was again entered as nuisance covariate. In each model, the white matter (WM) tracts comprising the network of interest were entered as independent variables. Only the "risk-network" results are represented here. **(A)** The predicted value of the BBr is plotted against the FA of the right anterior thalamic radiations (ATR); **(B,C)** the predicted value of the BIS is plotted against the FA of the right ATR **(B)** and of the right accumbofrontal fasciculus **(C)**; **(D)** the predicted value of the BAS Drive subscale is plotted against the ADC of the right ATR. Details regarding the results can be found in Table [4](#T4){ref-type="table"}.](fnhum-12-00075-g0003){#F3}

Association between the Neuropsychological Scores and "Obesity-Associated Tracts" Diffusivity {#s3-4}
---------------------------------------------------------------------------------------------

When testing the BIS/BAS scores, the BBr was significantly associated with the FA of the left (*p* \< 0.003) and right (*p* \< 0.005) hippocampal part of the cingulum, and approached significance for several other WM tracts (Table [5](#T5){ref-type="table"}). Moreover, the genotype approached significance for an association with the BIS score (*p* \< 0.04, uncorrected). No associations were found between the ADC of the "obesity-associated tracts" and the BIS/BAS scores or genotype.

###### 

Significant correlations between the neuropsychological scores, genotype and the "obesity-associated network" WM tracts.

  Score                   WM tract                *F*    *η*^2‡^   Sig.
  ----------------------- ----------------------- ------ --------- -----------
  FRACTIONAL ANISOTROPY                                            
  BIS/BAS RATIO           Genotype                9.2    0.568     0.019
                          Left CGH                20.3   0.743     0.003\*\*
                          Right CGH               16.2   0.669     0.005\*\*
                          Right Cingulate Gyrus   9.9    0.586     0.016
                          Left temporal SLF       6.1    0.464     0.043
                          Right temporal SLF      8.4    0.546     0.023
  BIS                     Genotype                5.7    0.449     0.048
                          Left CGH                8.9    0.561     0.020

*η^2^ = partial eta squared. ^‡^Small effect size: 0.10 ≤ η^*2*^ \< 0.3; medium effect size: 0.3 ≤ η^2^ \< 0.5; large effect size: η^2^ ≥ 0.5. \*\*Significant after correction for multiple comparisons*.

Discussion {#s4}
==========

We hypothesized that WM microstructure in specific regions of the reward network would be altered in individuals with genetic risk for obesity despite most of the participants had not yet developed obesity, reflecting the presence of a microstructural damage already at preclinical stages. We have thus tested WM integrity in 21 male participants genotyped on the *FTO* risk SNP rs9939609, through a deterministic tractography analysis. We have detected an effect of genotype, as well as an interaction effect of genotype and BMI, on the WM FA in the "risk tracts" (ATR and accumbofrontal fasciculus), but not in the "obesity-associated" tracts. Our results may suggest that an alteration of the WM connectivity within the central region (basal ganglia) of the brain is already present at subclinical stage in carriers of FTO-risk allele for obesity.

The accumbofrontal fasciculus and the ATR are part of a corticostriatothalamocortical loop (Rigoard et al., [@B40]), which has been previously reported to be disrupted in obesity (Marqués-Iturria et al., [@B30]; Kullmann et al., [@B26]; Papageorgiou et al., [@B36]). The thalamus WM connectivity, in particular, has been found to be altered in early-life obesity (Ou et al., [@B35]), and it has been suggested as a potential imaging predictor of BMI in obese people (Park et al., [@B37]). The accumbofrontal fasciculus, on the other hand, undergoes remarkable structural changes during the life-span, with patterns consistent with developmental models of decision-making (Karlsgodt et al., [@B25]). The GM volume of the nucleus accumbens has been reported to be lower in the at-risk AA carriers of the *FTO* SNP rs9939609 (de Groot et al., [@B10]). Moreover, the expression of the serotoninergic receptor 5-HT4 in nucleus accumbens has been reported to be upregulated in obesity, and the level of expression correlated with BMI (Iozzo, [@B22]). Due to its key role in reward and punishment (Dehkordi et al., [@B11]; Shin et al., [@B45]), the nucleus accumbens has been suggested as a target for deep brain stimulation for obesity treatment (Nangunoori et al., [@B34]).

Only two studies have so far investigated whether brain structural connectivity might be damaged in people with genetic risk for obesity (Dennis et al., [@B12]; Spieker et al., [@B51]). Dennis et al. ([@B12]) reported an association of WM integrity in several brain structures with only one gene (NEGR1) out of the 14 obesity-gene selected. While the *FTO* SNP rs9939609 was not included in their analysis, other two *FTO* SNPs were considered (Dennis et al., [@B12]). Spieker et al. ([@B51]) on the other hand, reported a shared genetic variance between obesity and WM integrity in 10 WM tracts selected *a priori*. The accumbo-frontal fasciculus was not included in this study. Moreover, they used a heritability analysis, where heritability is the proportion of total phenotypic variance that is explained by additive genetic factors (Spieker et al., [@B51]). Thus, no information regarding the specific genes involved was provided. One study investigating WM hyperintensities, reflective of WM vascular damage, failed to demonstrate any association between the *FTO* gene and WM burden (Ho et al., [@B21]). However, this study was carried out in elderly participants (with a mean age of 76 years; Ho et al., [@B21]), when WM vascular damage is frequently observed in the general population (Yoshita et al., [@B61]; Sachdev et al., [@B41]).

We suggest that a very close relationship between genetic background, neurovascular-coupling and WM disruption in regional connectivity of central regions of the brain might act together as a predisposing factor for the development of obesity. Neurovascular coupling is in fact associated with neuroinflammatory processes and WM integrity (Soto et al., [@B49]; Wilhelm et al., [@B56]). Central reward-related regions within basal ganglia such as thalamus and the nucleus accumbens are particularly vulnerable to pressure dysregulation (Moody et al., [@B32]; Perles-Barbacaru et al., [@B38]; Iozzo, [@B22]). The thalamus and the basal ganglia, in fact, have a peculiar vascular organization, characterized by long arterioles and long muscular arteries, supplied by adjacent sources at the base of the brain (Moody et al., [@B32]). The terminal arterioles, often narrow and short, do not interdigitate with the terminal arterioles of adjacent territories, posing a greater risk for hypoperfusion and anoxia in these regions compared to other brain territories (Moody et al., [@B32]). The nucleus accumbens in particular has been reported to be more vulnerable to pressure dysregulation compared to the other regions (Perles-Barbacaru et al., [@B38]), mainly because of the local expression of dopamingergic receptors (Frank, [@B15]). Dopamine plays a key role in neurovascular coupling and pressure regulation (Perles-Barbacaru et al., [@B38]). The reward network is enriched in dopamine receptors (Choi et al., [@B9]), and a disruption of dopaminergic signaling, particularly through an hyposensitivity of receptors D2 and D3, has been reported in obesity (Frank, [@B15]). The activity of the receptors D2 and D3 is also regulated by the *FTO* gene (Hess et al., [@B20]; Sevgi et al., [@B44]; Heni et al., [@B19]). Hence, it seems reasonable to think that some of the increased dietary intake and unhealthy eating behaviors identified in carrier of the *FTO* risk variants (Brunkwall et al., [@B3]) might be associated to an early dysfunction of the WM connectivity of these regions due to a vascular damage on genetic based risk.

We found an effect of the *FTO* risk allele on the FA, rather than the ADC, of the "risk-tracts". This discrepancy might be due to the different sensitivity that ADC and FA have toward different neural maturation processes, such as fiber organization, myelination, and proliferation and maturation of glial cell bodies and intracellular compartments (Provenzale et al., [@B39]), particularly during neurogenesis. Indeed, ADC and FA do not necessarily correlate with each other (Provenzale et al., [@B39]; Leong et al., [@B27]), and the relationship between ADC and FA values varies for different WM tracts (Provenzale et al., [@B39]). The FTO gene has been reported to be involved in neurogenesis in mice (Li et al., [@B28]). Though the underlying mechanisms are still unclear, it is therefore likely that it might affect differently the FA and the ADC of WM tracts.

Future longitudinal studies will be needed to investigate whether WM microstructural changes in specific regions of the reward network can indeed be regarded as a first step in the development of obesity in carrier of the *FTO* at-risk allele. Moreover, our sample was small, and included only male participants, calling for other studies with larger and more heterogeneous cohorts, possibly including also heterozygous *FTO* AT allele carriers, to verify our findings. Finally, we used a deterministic tractography approach with manually defined ROIs for tracts definition. The ROIs were carefully defined according to previous literature and a blind check was carried out by a second operator, however automated techniques and atlas ROIs might be used to avoid any potential bias in ROIs design.

Conclusion {#s5}
==========

We report an alteration of WM microstructure in the accumbofrontal fasciculi and ATR of males with the AA at-risk allele of the *FTO* SNP rs9939609, compared to the non-risk allele TT. We suggest that ATR and accumbofrontal fasciculi damage might be a predisposing factor for obesity at brain level in the AA allele carriers. Such damage might derive from the interplay between genetic background, altered neurovascular-coupling and the high susceptibility of the thalamus and nucleus accumbens to vascular damage, due to their peculiar anatomo-vascular characteristics. The disruption in dopaminergic signaling, caused by changes in expression and sensitivity of dopaminergic receptors induced by the risk-allele, might in fact lead to an altered neurovascular coupling in the reward network, which in turn might contribute in determining WM microstructural damage in highly vulnerable regions such the thalamus and nucleus accumbens.
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